All News

Daniela Vergara, PhD, discusses her work with on the production of photo periods and the importance of data sharing.

We’re halfway through 2025, so let’s revisit the top five articles this year covering research, regulations, and other industry insights.

The results highlight gender disparities, uncertainty about vape contents, and the growing use of synthetic products.

Expanding the organizations’ accredited safety and quality certification program, CSQ is adding new standards for cannabis retail, warehousing, and distribution.

Daniela Vergara, PhD, explains her work with the Cornell Cooperative Extension.

“Operation Safe Summer” removed nearly 11,000 noncompliant hemp packages in first week of enforcement, citing violations of child-protection standards.

New leadership to the Cannabis Control Board and the Office of Cannabis Management was announced, as well as updates to recent developments in licenses and more.

HB 952, a bill that would have allow for tribal nations and the governor’s office to be able to form compacts to legalize cannabis and regulate it on individual reservations.

In this interview clip from our Women in Grow: Leadership in Cannabis Genetics and Cultivation supplement, Anna Schwabe, PhD explains the cannabis projects and companies she is actively involved in, her goals for the future, plus past guests on her podcast, The Dank Hour.

Here, we bring you our top five recent articles covering medical cannabis in Texas, cease-and-desist letter response, pardons in Maryland, cannabis in Thailand, and research on autism and cannabis.

Intoxicating hemp-derived THC products are now banned in Arkansas and creates a little bit of controversy regarding the recent bill veto by Texas Governor Abbott.

The newly published regulations classify cannabis flowers as controlled herbs, requiring prescriptions and licensed handling.

Wyld has joined The Conservation Alliance as a Pinnacle Member and becomes the first cannabis brand to reach this level.

The acquisition is anticipated to provide a foothold in two states and allow for further expansion in additional locations.

ONE HEMP announced their support of the SB 3 veto from Texas Governor Greg Abbott.

Results included improvements in aggression, hyperactivity, and communication, but a strong placebo effect was also observed.

Texas Governor, Greg Abbott, signed HB 46 into law, which made the Lone Star State the 40th state in the US to legalize medical cannabis use.

Industry organizations respond after Governor Greg Abbott vetoed SB 3, citing safety and legal concerns.

Strong Strains recently responded to the cease-and-desist letter from the property owners regarding their new Long Island dispensary in East Setauket, New York.

Maryland Governor Wes Moore announced that he would be pardoning 7,000 people who had been convicted of crimes related to cannabis.

Here, we bring you our top five recent articles covering medical cannabis in Hawaii, a new dispensary in Connecticut, pesticide testing in California, a cease-and-desist letter to a dispensary on Long Island, and a global survey on cannabis for endometriosis.

In this interview clip from our Women in Grow: Leadership in Cannabis Genetics and Cultivation supplement, Anna Schwabe, PhD shares insights into genetic characteristics of the cannabis plant and potential research into disease resistance.

The study tested the effects of real-world cannabis products categorized by four modes of administration: dabbing, vaping, bong-like, or joint-like products.

A legal cannabis dispensary on Long Island, located within the Brookhaven Town, received a cease-and-desist letter before their upcoming grand opening.

Proposed regulations from the Department of Health would make permanent the emergency rules banning THC in hemp-derived food, beverage, and dietary products while restricting sales to adults 21 and older.

C3 Industries announced the recent opening of their new High Profile Stratford Connecticut dispensary.

A survey of nearly 900 endometriosis patients across 28 countries highlights cannabis as a preferred alternative to pharmaceuticals, despite legal, social, and medical communication barriers.

New Jersey Department of State’s NJBAC completed the CTA program which helps educate businesses on the states’ cannabis industry.

Proposed changes include revised action levels for 31 pesticides and the addition of 14 pesticides for required testing.

A recent study found that CBD gummies may not have accurate labeling on how much the cannabinoid it contains.